The trajectory of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced substantial uncertainty . Investors are now facing the effect of generic competition , shr